Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma
系统生物学方法识别总体生存率低的预后特征并指导骨肉瘤新型 BET-CHK1 联合疗法的优先顺序
期刊:Cancers
影响因子:
doi:10.3390/cancers12092426
Pankita H Pandya, Lijun Cheng, M Reza Saadatzadeh, Khadijeh Bijangi-Vishehsaraei, Shan Tang, Anthony L Sinn, Melissa A Trowbridge, Kathryn L Coy, Barbara J Bailey, Courtney N Young, Jixin Ding, Erika A Dobrota, Savannah Dyer, Adily Elmi, Quinton Thompson, Farinaz Barghi, Jeremiah Shultz, Eric A Albr
